Popular content creator, Jarvis, has opened up about her decision to take a break from portraying her AI robot character following backlash from trolls and netizens. The content creator, who gained fame for her robotic persona, faced criticism after she stepped away from this role to play the character of Pellerβs girlfriend instead.
According to Gistreel, many fans expressed their disappointment and confusion over her departure from the beloved character, prompting a public outcry. In light of the criticism, Jarvis decided to address the situation directly in a recent video, providing insight into her absence from her AI role.

In her candid video, she revealed that her break was not merely a response to the trolls but was also due to a serious health-related issue. Jarvis disclosed that she has been diagnosed with a tumor in her jawline, which prompted her to pause her performances as the robot character. Initially, she believed the slight bulge on her jaw was a tooth-related problem, but after consulting her doctor, she was informed that it was, in fact, a tumor that required further investigation.
She explained that a surgical procedure was necessary, during which doctors had to cut her jaw open to test the tumor and determine its nature. This diagnosis understandably affected her ability to continue her work, leading to her hiatus from the role that initially made her famous.
[h2>Netizensβ reactions below β¦@iamenic humorously commented, βThe dragging dn finally touch her.. πI comot cap for X people, you no fit do anyhow for here πππ.β
@iAmmiira_ remarked, βSee as Twitter people just dey make this girl explain. Stay strong dear.β
@emmexlonely added, βShe finally said it. I been asking this question since last week say she put egg for cheeks.β
@Talk2meeh expressed hope, saying, βI hope we become kinder.β
Watch the video below β¦[/p>
I have a tumor in my jawline β TikTok influencer, Jarvis explains why she took a break from playing her famous character pic.twitter.com/HIQM9IwqPS
β Instablog9ja (@instablog9ja) October 17, 2024






